Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950137-04-002378
Filing Date
2004-03-30
Accepted
2004-03-30 16:50:14
Documents
9
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT c84130e10vk.txt 10-K 354722
3 2003 STOCK OPTION PLAN c84130exv10w35.txt EX-10.35 34902
4 NON-QUALIFIED STOCK OPTION AGREEMENT c84130exv10w36.txt EX-10.36 10181
5 INCENTIVE STOCK OPTION AGREEMENT c84130exv10w37.txt EX-10.37 11034
6 SUBSIDIARIES OF THE REGISTRANT c84130exv21w1.txt EX-21.1 387
7 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER c84130exv31w1.txt EX-31.1 3103
8 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER c84130exv31w2.txt EX-31.2 3106
9 906 CERTIFICATIO OF CHIEF EXECUTIVE OFFICER c84130exv32w1.txt EX-32.1 1190
10 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER c84130exv32w2.txt EX-32.2 1191
  Complete submission text file 0000950137-04-002378.txt   422460
Mailing Address 100 TRI STATE INTERNATIONAL SUITE 100 LINCOLNSHIRE IL 60069
Business Address 2500 MILLBROOK DRIVE BUFFALO GROVE IL 60089 8472796100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

EIN.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-13976 | Film No.: 04701911
SIC: 2834 Pharmaceutical Preparations